A randomised phase II trial of capecitabine plus cisplatin versus S-1 plus cisplatin as a first-line treatment for advanced gastric cancer: Capecitabine plus cisplatin ascertainment versus S-1 plus cisplatin randomised PII trial (XParTS II)

A randomised phase II trial of capecitabine plus cisplatin versus S-1 plus cisplatin as a first-line treatment for advanced gastric cancer: Capecitabine plus cisplatin ascertainment versus S-1 plus cisplatin randomised PII trial (XParTS II)

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: European Journal of Cancer - Volume 101, September 2018, Pages 220-228

Kazuhiro Nishikawa, Akira Tsuburaya, Takaki Yoshikawa, Michiya Kobayashi, Junji Kawada, Ryoji Fukushima, Takanori Matsui, Kazuaki Tanabe, Kazuya Yamaguchi, Shigefumi Yoshino, Masazumi Takahashi, Naoki Hirabayashi, Seiji Sato, Hiroshi Nemoto,